Global dementia cases are set to triple, but what does this mean, what are we doing and how can you help?
With global dementia cases are set to triple by 2050 to no fewer than 152 million, we share what you can do to help.
This year, the world’s largest dementia research conference – the Alzheimer’s Association International Conference (AAIC) – went virtual. Here are our top seven highlights from the week!
Conferences like AAIC are helping to bring about real breakthroughs and we were there to bring you the latest findings. Here are 6 interesting developments we learnt!
Many studies are now looking at lifestyle factors in early adulthood and midlife, to see how they are related to brain health and dementia in later life.
One of these other forms of dementia is posterior cortical atrophy (PCA), which is a rare subtype of Alzheimer’s disease.
‘How can I prevent dementia?’ is one of the most common questions we hear at Alzheimer’s Research UK. And no wonder: without treatments to affect the underlying diseases, it’s natural for people to look for ways to stave off the condition. It’s also hugely important for government, as action to help people reduce their dementia risk should mean fewer people developing the condition in future.
Prof Lovestone spoke about two projects where patients have agreed to share their medical records anonymously – allowing researchers to spot trends about how diseases like Alzheimer’s develop, or for example, what biological changes in the body might be used to help diagnose the disease earlier and more accurately.
In recent years, we’ve seen several trials of anti-amyloid drugs shelved after failing to benefit patients, so is it time to rethink the whole amyloid approach?
In recent months, there have been a number of reports in the media on the emerging link between blows to the head, contact sports and dementia. This week at Alzheimer’s Association International Conference 2017 we had the opportunity to hear from scientists to learn what research is going on.
On the final day of last month’s Alzheimer’s Association International Conference in Toronto, we heard from Dr Jane Ann Driver, a cancer scientist who moved disciplines and took the leap into dementia research. This experience gave her a valuable perspective on dementia research, allowing her to impart lessons learned in cancer research and to highlight important similarities and differences between the two areas.